No abstract

No abstract

Many patients have died in ICUs worldwide during the COVID-19 pandemic. They were cared for by multidisciplinary health care professionals who did their best but who were often working at the limit of their technological, psychological, physical, and cognitive abilities. 5 In pre-pandemic times, in adult critical care a decision on limiting treatment was often made beforehand for many patients in the ICU. 6 As a result, dying sometimes became a relatively predictable process in ICUs, where distressing symptoms such as dyspnoea or anxiety were alleviated, relatives were involved, and support services could be consulted. 7,8 Successful models for palliative care delivery and quality improvement in the ICU setting have been widely studied in the past. 8,9 Based on recommendations from the Improving Palliative Care The Department of Intensive Care Medicine has, or has had in the past, research and development/consulting contracts with Edwards Lifesciences Services GmbH, Phagenesis Limited, and Nestlé. The money was paid into a departmental fund, and none of the authors received any financial gain. The Department of Intensive Care Medicine has received in the past unrestricted educational grants from the following organizations for organizing bi-annual postgraduate courses in the fields of critical care ultrasound, management of ECMO, and mechanical ventilation: Pierre Fabre Pharma AG (formerly known as RobaPharm), Pfizer AG,

No abstract